Lung Cancer Clinical Trials

Showing 2721-2740 of 4,288 trials

A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC

NCT04612673

The purpose of this study is to to explore the efficacy and safety of PD-1 immune check point inhibitor, sintilimab, in biomarker-selected subjects with advanced or metastatic Non-small Cell Lung Cancer who have failed from standard front-line treatment.

Non-small Cell Lung Cancer

China Medical University, China33 participantsStarted Nov 2020

Shenyang, Liaoning, China

UNKNOWNPhase 2/3

Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)

NCT03288870

International multi-center open-label randomized clinical trial of efficacy, safety and pharmacokinetics of BCD-100 (JSC BIOCAD, Russia) monotherapy compared to docetaxel as second-line therapy of patients with advanced inoperable or metastatic non-small cell lung cancer

Non Small Cell Lung Cancer Stage IIIBNon-Small Cell Carcinoma of Lung, TNM Stage 4

Biocad218 participantsStarted Sep 2017

Homyel, Belarus • Arkhangelsk, Russia • Krasnodar, Russia +5 more locations

COMPLETED

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

NCT00453661

The goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer. A secondary outcome of this demonstration project proposes that a structured patient navigator (PN) will reduce the cost of Medicare services.

Breast CancerCervical CancerProstate Cancer+2 more

M.D. Anderson Cancer Center2,472 participantsStarted Mar 2007

Houston, Texas, United States

A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC

Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)

Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities

Related Searches

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Phase I Combination Ixabepilone + Cisplatin

Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label

Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung Cancer

Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel

Single Arm on the Tolerability of Weekly Nab-paclitaxel

Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis

Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients

A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Thoracotomy Closure Technique and Postoperative Pain Study: A Randomized Controlled Trial

Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer

A Preliminary Study on the Detection of Plasma Markers in Early Diagnosis for Lung Cancer

A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers